RecruitingNot applicableNCT07287176

Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System

Studying Familial LCAT deficiency

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pulse Biosciences, Inc.
Principal Investigator
Ralph Tufano, MD
Sarasota Memorial Hospital
Intervention
nPulse Vybrance Percutaneous Electrode System(device)
Enrollment
100 target
Eligibility
22-80 years · All sexes
Timeline
2025 – 2027

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07287176 on ClinicalTrials.gov

Other trials for Familial LCAT deficiency

Additional recruiting or active studies for the same condition.

See all trials for Familial LCAT deficiency →

← Back to all trials